about
Pharmacometabolomics-aided Pharmacogenomics in Autoimmune DiseaseFrom Metabonomics to Pharmacometabonomics: The Role of Metabolic Profiling in Personalized MedicineApplying metabolomics to cardiometabolic intervention studies and trials: past experiences and a roadmap for the futureMetabolomics enables precision medicine: "A White Paper, Community Perspective"Revitalizing personalized medicine: respecting biomolecular complexities beyond gene expression.Pharmacometabolomics: implications for clinical pharmacology and systems pharmacology.Pharmacometabolomics of l-carnitine treatment response phenotypes in patients with septic shock.The promise of metabolic phenotyping in gastroenterology and hepatology.Translational biomarkers of acetaminophen-induced acute liver injuryGenetic polymorphisms of pharmacogenomic VIP variants in the Mongol of Northwestern China.Other side of the coin for personalised medicine and healthcare: content analysis of 'personalised' practices in the literaturePharmacometabolomics study identifies circulating spermidine and tryptophan as potential biomarkers associated with the complete pathological response to trastuzumab-paclitaxel neoadjuvant therapy in HER-2 positive breast cancer.Pharmacometabolomics in Early-Phase Clinical Development.Metabolic phenotyping applied to pre-clinical and clinical studies of acetaminophen metabolism and hepatotoxicity.Pharmacometabonomics in humans: a new tool for personalized medicine.Metabolomics applications in precision medicine: An oncological perspective.Omics for Understanding the Gut-Liver-Microbiome Axis and Precision Medicine.A guide to the identification of metabolites in NMR-based metabonomics/metabolomics experiments.A new paradigm for known metabolite identification in metabonomics/metabolomics: metabolite identification efficiency.The emergent role of metabolic phenotyping in dynamic patient stratification.Recent trends on the role of epigenomics, metabolomics and noncoding RNAs in rationalizing mood stabilizing treatment.Microfluidic Organ-on-a-Chip Models of Human Intestine.A Metabolomics Approach to Pharmacotherapy Personalization
P2860
Q26748481-2273A63E-3F7A-4DA4-B50B-EFF78BCB8B49Q28067029-8D598E32-659E-49F5-A95A-55AAC7C286ECQ28074451-C11D0F3B-8D5E-4C36-A7E8-CDE490C38C27Q28831476-12161CF0-C011-46C3-AFBB-E62D906E9581Q33570878-9BEAE70A-5D35-4413-A90E-4CCFEFE98FDDQ35032056-3ACF0DAD-4321-40E7-8C63-1BFB385AF1B5Q35127737-18DC34D9-AEEC-4764-93DA-DC6B85FB1E6FQ35701279-617BD4F0-68F8-4C14-B8A5-E4993B0E53AEQ36001451-9E122351-05BB-4668-8B69-6061CEB9BB3FQ36032764-D949CD6A-322A-4682-9A8F-FE319C959D9EQ37100793-91E16FAA-A446-4EAC-9CF3-0674FF0CC7CEQ37457684-245B51C1-EE56-4556-8F4D-B7655D74D941Q37701143-8F05F2EB-AD20-48CD-AA7B-7F2F6D39090CQ38297772-EB489427-9313-4D38-881B-9687B7AE5F62Q38452107-7150156A-A7A2-4509-90B6-4369356A1014Q38689857-3D2EB03D-36C5-46C3-85AF-E925A5D61732Q38750137-EA9D3E38-5848-4AD1-A5B0-18EF8076700DQ39884399-9BE1D39B-D9C0-4D7B-8E6D-B691B8151FC8Q41773657-0F8FFF59-7318-4501-BED0-D99D6C05C54AQ45138155-4238D13A-2AB0-494C-9FC6-27A0BDC1F1BAQ49332592-EFF3F238-6CE1-47AE-9DAF-E7C568C034C5Q55035407-9DCFD45A-F747-4DC1-BD9B-A0A2EC7C7EABQ58762484-4044FDE4-EA32-4FB8-B8FB-3302FB0563DF
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Pharmacometabonomics and personalized medicine.
@en
type
label
Pharmacometabonomics and personalized medicine.
@en
prefLabel
Pharmacometabonomics and personalized medicine.
@en
P2860
P356
P1476
Pharmacometabonomics and personalized medicine.
@en
P2093
Francis S Pullen
Jeremy R Everett
P2860
P304
P356
10.1177/0004563213497929
P577
2013-07-25T00:00:00Z